Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Standard Biotools (LAB) Leases (2019 - 2026)

Standard Biotools has reported Leases over the past 7 years, most recently at $26.7 million for Q4 2025.

  • Quarterly Leases rose 0.62% to $26.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.7 million through Dec 2025, up 0.62% year-over-year, with the annual reading at $26.7 million for FY2025, 0.62% up from the prior year.
  • Leases was $26.7 million for Q4 2025 at Standard Biotools, up from $23.5 million in the prior quarter.
  • Over five years, Leases peaked at $38.7 million in Q2 2021 and troughed at $23.5 million in Q3 2025.
  • The 5-year median for Leases is $32.6 million (2023), against an average of $32.1 million.
  • Year-over-year, Leases grew 4.33% in 2021 and then fell 22.51% in 2025.
  • A 5-year view of Leases shows it stood at $37.1 million in 2021, then decreased by 8.72% to $33.9 million in 2022, then dropped by 9.5% to $30.7 million in 2023, then dropped by 13.36% to $26.6 million in 2024, then increased by 0.62% to $26.7 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Leases are $26.7 million (Q4 2025), $23.5 million (Q3 2025), and $24.6 million (Q2 2025).